Kairos Pharma Ltd. (KAPA)
0.505
+0.03
(+6.65%)
USD |
NYAM |
Nov 03, 16:00
0.486
-0.02
(-3.76%)
After-Hours: 20:00
Kairos Pharma Shareholders Equity (Quarterly) : 4.191M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 4.191M |
| March 31, 2026 | 5.313M |
| December 31, 2025 | 6.341M |
| September 30, 2025 | 7.664M |
| June 30, 2025 | 5.997M |
| March 31, 2025 | 7.132M |
| December 31, 2024 | 4.776M |
| September 30, 2024 | 3.332M |
| Date | Value |
|---|---|
| June 30, 2024 | -2.654M |
| March 31, 2024 | -2.401M |
| December 31, 2023 | -2.078M |
| September 30, 2023 | -1.873M |
| June 30, 2023 | -1.561M |
| March 31, 2023 | -1.325M |
| December 31, 2022 | -1.179M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Alnylam Pharmaceuticals, Inc. | 3.604B |
| Anika Therapeutics, Inc. | 137.28M |
| Savara, Inc. | 143.66M |
| Vericel Corp. | 370.04M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 4.456M |
| Total Liabilities (Quarterly) | 0.265M |
| Current Ratio | 11.98 |